239 related articles for article (PubMed ID: 35266292)
1. The seventh international RASopathies symposium: Pathways to a cure-expanding knowledge, enhancing research, and therapeutic discovery.
Kontaridis MI; Roberts AE; Schill L; Schoyer L; Stronach B; Andelfinger G; Aoki Y; Axelrad ME; Bakker A; Bennett AM; Broniscer A; Castel P; Chang CA; Cyganek L; Das TK; den Hertog J; Galperin E; Garg S; Gelb BD; Gordon K; Green T; Gripp KW; Itkin M; Kiuru M; Korf BR; Livingstone JR; López-Juárez A; Magoulas PL; Mansour S; Milner T; Parker E; Pierpont EI; Plouffe K; Rauen KA; Shankar SP; Smith SB; Stevenson DA; Tartaglia M; Van R; Wagner ME; Ware SM; Zenker M
Am J Med Genet A; 2022 Jun; 188(6):1915-1927. PubMed ID: 35266292
[TBL] [Abstract][Full Text] [Related]
2. The 8th International RASopathies Symposium: Expanding research and care practice through global collaboration and advocacy.
Pierpont EI; Bennett AM; Schoyer L; Stronach B; Anschutz A; Borrie SC; Briggs B; Burkitt-Wright E; Castel P; Cirstea IC; Draaisma F; Ellis M; Fear VS; Frone MN; Flex E; Gelb BD; Green T; Gripp KW; Khoshkhoo S; Kieran MW; Kleemann K; Klein-Tasman BP; Kontaridis MI; Kruszka P; Leoni C; Liu CZ; Merchant N; Magoulas PL; Moertel C; Prada CE; Rauen KA; Roelofs R; Rossignol R; Sevilla C; Sevilla G; Sheedy R; Stieglitz E; Sun D; Tiemens D; White F; Wingbermühle E; Wolf C; Zenker M; Andelfinger G
Am J Med Genet A; 2024 Apr; 194(4):e63477. PubMed ID: 37969032
[TBL] [Abstract][Full Text] [Related]
3. The RASopathies: from pathogenetics to therapeutics.
Hebron KE; Hernandez ER; Yohe ME
Dis Model Mech; 2022 Feb; 15(2):. PubMed ID: 35178568
[TBL] [Abstract][Full Text] [Related]
4. The sixth international RASopathies symposium: Precision medicine-From promise to practice.
Gripp KW; Schill L; Schoyer L; Stronach B; Bennett AM; Blaser S; Brown A; Burdine R; Burkitt-Wright E; Castel P; Darilek S; Dias A; Dyer T; Ellis M; Erickson G; Gelb BD; Green T; Gross A; Ho A; Holder JL; Inoue SI; Jelin AC; Kennedy A; Klein R; Kontaridis MI; Magoulas P; McConnell DB; McCormick F; Neel BG; Prada CE; Rauen KA; Roberts A; Rodriguez-Viciana P; Rosen N; Rumbaugh G; Sablina A; Solman M; Tartaglia M; Thomas A; Timmer WC; Venkatachalam K; Walsh KS; Wolters PL; Yi JS; Zenker M; Ratner N
Am J Med Genet A; 2020 Mar; 182(3):597-606. PubMed ID: 31825160
[TBL] [Abstract][Full Text] [Related]
5. Autism traits in the RASopathies.
Adviento B; Corbin IL; Widjaja F; Desachy G; Enrique N; Rosser T; Risi S; Marco EJ; Hendren RL; Bearden CE; Rauen KA; Weiss LA
J Med Genet; 2014 Jan; 51(1):10-20. PubMed ID: 24101678
[TBL] [Abstract][Full Text] [Related]
6. Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies.
Gross AM; Frone M; Gripp KW; Gelb BD; Schoyer L; Schill L; Stronach B; Biesecker LG; Esposito D; Hernandez ER; Legius E; Loh ML; Martin S; Morrison DK; Rauen KA; Wolters PL; Zand D; McCormick F; Savage SA; Stewart DR; Widemann BC; Yohe ME
Am J Med Genet A; 2020 Apr; 182(4):866-876. PubMed ID: 31913576
[TBL] [Abstract][Full Text] [Related]
7. Rasopathies - dysmorphic syndromes with short stature and risk of malignancy.
Cizmarova M; Kostalova L; Pribilincova Z; Lasabova Z; Hlavata A; Kovacs L; Ilencikova D
Endocr Regul; 2013 Oct; 47(4):217-22. PubMed ID: 24156711
[TBL] [Abstract][Full Text] [Related]
8. The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathway.
Stevenson DA; Schill L; Schoyer L; Andresen BS; Bakker A; Bayrak-Toydemir P; Burkitt-Wright E; Chatfield K; Elefteriou F; Elgersma Y; Fisher MJ; Franz D; Gelb BD; Goriely A; Gripp KW; Hardan AY; Keppler-Noreuil KM; Kerr B; Korf B; Leoni C; McCormick F; Plotkin SR; Rauen KA; Reilly K; Roberts A; Sandler A; Siegel D; Walsh K; Widemann BC
Am J Med Genet A; 2016 Aug; 170(8):1959-66. PubMed ID: 27155140
[TBL] [Abstract][Full Text] [Related]
9. Malignancy in Noonan syndrome and related disorders.
Smpokou P; Zand DJ; Rosenbaum KN; Summar ML
Clin Genet; 2015 Dec; 88(6):516-22. PubMed ID: 25683281
[TBL] [Abstract][Full Text] [Related]
10. Senescence in RASopathies, a possible novel contributor to a complex pathophenoype.
Engler M; Fidan M; Nandi S; Cirstea IC
Mech Ageing Dev; 2021 Mar; 194():111411. PubMed ID: 33309600
[TBL] [Abstract][Full Text] [Related]
11. New prospectives on treatment opportunities in RASopathies.
Gelb BD; Yohe ME; Wolf C; Andelfinger G
Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):541-560. PubMed ID: 36533679
[TBL] [Abstract][Full Text] [Related]
12. Clinical manifestations of mutations in RAS and related intracellular signal transduction factors.
Zenker M
Curr Opin Pediatr; 2011 Aug; 23(4):443-51. PubMed ID: 21750428
[TBL] [Abstract][Full Text] [Related]
13. An Assessment of the Therapeutic Landscape for the Treatment of Heart Disease in the RASopathies.
Yi JS; Perla S; Bennett AM
Cardiovasc Drugs Ther; 2023 Dec; 37(6):1193-1204. PubMed ID: 35156148
[TBL] [Abstract][Full Text] [Related]
14. A review of craniofacial and dental findings of the RASopathies.
Cao H; Alrejaye N; Klein OD; Goodwin AF; Oberoi S
Orthod Craniofac Res; 2017 Jun; 20 Suppl 1(Suppl 1):32-38. PubMed ID: 28643916
[TBL] [Abstract][Full Text] [Related]
15. [New insight of craniofacial and oral findings of the RASopathies].
Cao HT; Yang YJ; Zheng Q; Shi B; Li CH
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Dec; 53(12):858-861. PubMed ID: 30522213
[TBL] [Abstract][Full Text] [Related]
16. First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics.
Rauen KA; Alsaegh A; Ben-Shachar S; Berman Y; Blakeley J; Cordeiro I; Elgersma Y; Evans DG; Fisher MJ; Frayling IM; George J; Huson SM; Kerr B; Khire U; Korf B; Legius E; Messiaen L; van Minkelen R; Nampoothiri S; Ngeow J; Parada LF; Phadke S; Pillai A; Plotkin SR; Puri R; Raji A; Ramesh V; Ratner N; Shankar SP; Sharda S; Tambe A; Vikkula M; Widemann BC; Wolkenstein P; Upadhyaya M
Am J Med Genet A; 2019 Jun; 179(6):1091-1097. PubMed ID: 30908877
[TBL] [Abstract][Full Text] [Related]
17. Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients.
Levin MD; Saitta SC; Gripp KW; Wenger TL; Ganesh J; Kalish JM; Epstein MR; Smith R; Czosek RJ; Ware SM; Goldenberg P; Myers A; Chatfield KC; Gillespie MJ; Zackai EH; Lin AE
Am J Med Genet A; 2018 Aug; 176(8):1711-1722. PubMed ID: 30055033
[TBL] [Abstract][Full Text] [Related]
18. Dermatological manifestations, management, and care in RASopathies.
Kavamura MI; Leoni C; Neri G
Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):452-458. PubMed ID: 36541891
[TBL] [Abstract][Full Text] [Related]
19. RASopathies: Dermatologists' viewpoints.
Palit A; Inamadar AC
Indian J Dermatol Venereol Leprol; 2022; 88(4):452-463. PubMed ID: 35138057
[TBL] [Abstract][Full Text] [Related]
20. RASopathies for Radiologists.
Handa A; Tsujioka Y; Nishimura G; Nozaki T; Kono T; Jinzaki M; Harms T; Connolly SA; Sato TS; Sato Y
Radiographics; 2024 May; 44(5):e230153. PubMed ID: 38602868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]